Loading clinical trials...

COMPLETEDNA

Exercise to Prevent Depression and Anxiety in Older Hispanics

NCT02371954•University of Miami

Summary

The study is a randomized pilot trial of a health promotion intervention in the prevention of anxiety and depression in older Hispanics.

Detailed Description

Eligible participants will be randomized to either the Happy Older Latinos are Active (HOLA) intervention or a psychoeducation condition. Participants randomized to HOLA will participate in a group exercise, 3 times a week, for 16 weeks. The exercise is a moderate intensity walk at a centrally located park in Miami-Dade county and will last for an hour (10 minute warmup/stretching, 30 minute walk, 5 minute cool down). Groups will consist of 6 participants and be led by a community health worker. During the cool down phase, participants will plan a pleasant event to be done in between sessions. Participants randomized to the psychoeducation component will receive a fotonovela and will meet once a month after they receive the fotonovela to discuss their thoughts on the materials they received. These discussion groups will last one hour and will consist of 10 participants. A total of 60 participants will be randomized (30 to HOLA, 30 to fotonovela). Assessments will be conducted at baseline, post intervention, 6 months post-intervention, and 12 months post-intervention.

Eligibility

Age

60 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Hispanic (self-identified);
•2. Age 60+;
•3. Minor depression as defined by a primary DSM-IV Axis I diagnosis of minor depressive disorder or subthreshold depression defined as a score ≥ 3 on the Patient Health Questionnaire (PHQ-2), OR subthreshold anxiety as defined as a score ≥ 3 on the Generalized Anxiety Disorder-2 scale (GAD-2);
•4. Absence of episodes of major depression and anxiety disorders for past 12 months (as determined by the MINI);
•5. Voluntary informed consent for participation in the study by the participant or by the participant's legally designated guardian or conservator;
•6. Medical clearance for participation in an exercise program by a physician, physician's assistant, or nurse practitioner;
•7. Expect to be resident in Miami for the subsequent 12 months.

Exclusion Criteria

•1. Currently residing in a nursing or group home;
•2. A terminal physical illness expected to result in the death within one year;
•3. A diagnosis of dementia, co-morbid diagnosis of dementia, or significant cognitive impairment as indicated by an MMSE score \<24;
•4. Presence of any axis 1 psychiatric disorder or substance abuse during preceding 12 months;
•5. History of psychiatric disorders other than non-psychotic unipolar major depression or anxiety disorder;
•6. High suicide risk, i.e., intent or plan to attempt suicide in the near future (a response of "yes" to questions 3, 4, and/or 5 on the Paykel Questionnaire);
•7. Participants taking cognitive enhancing medication or psychotropic medications (e.g. antidepressants);
•8. unable to complete 400 m walk test in less than 15 min;
•9. if participant heart rate exceeded 170 beats per minute OR systolic blood pressure exceeds 180 during 400 m walk test;
•10. chest or leg pain, dyspnea, dizziness, feeling faint, or other significant symptoms while completing 400 m walk test;
+1 more criteria

Locations (1)

Jackson Memorial Mental Health Hospital

Miami, Florida, United States

Key Dates

Start Date

September 1, 2013

Primary Completion Date

August 1, 2018

Completion Date

August 1, 2018

Last Updated

September 7, 2018

Enrollment

ACTUAL participants

Conditions

AnxietyDepression

Interventions

Happy Older Latinos are Active

BEHAVIORAL

Fotonovela

OTHER

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 7, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Exercise to Prevent Depression and Anxiety in Older Hispanics

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures